Cargando…

Smartphone-guided secondary prevention for patients with coronary artery disease

INTRODUCTION: Coronary artery disease (CAD) is the leading cause of death worldwide. Lifestyle change is a crucial part of secondary prevention. Only 30% of CAD patients follow the corresponding guideline recommendations. The widespread adoption of smartphones offers the opportunity to integrate sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eckardt, Irina, Buschhaus, Clara, Nickenig, Georg, Jansen, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970225/ https://www.ncbi.nlm.nih.gov/pubmed/33796334 http://dx.doi.org/10.1177/2055668321996572

Ejemplares similares

A prospective, randomized, controlled, multicentre trial for secondary prevention in patients with chronic coronary syndrome using a smartphone application for digital therapy: the CHANGE study protocol
por: Düsing, Philip, et al.
Publicado: (2023)

Efficacy of Smartphone-Based Secondary Preventive Strategies in Coronary Artery Disease
por: Murphy, Alexandra C, et al.
Publicado: (2020)

Kinetics of Circulating MicroRNAs in Response to Cardiac Stress in Patients With Coronary Artery Disease
por: Jansen, Felix, et al.
Publicado: (2017)

Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus
por: Düsing, Philip, et al.
Publicado: (2023)

MicroRNA Expression in Circulating Microvesicles Predicts Cardiovascular Events in Patients With Coronary Artery Disease
por: Jansen, Felix, et al.
Publicado: (2014)

Development of Smartphone Educational Application for Patients with Coronary Artery Disease
por: Cho, Min Jung, et al.
Publicado: (2014)

The impact of dietary education and counselling with a smartphone application on secondary prevention of coronary artery disease: A randomised controlled study (the TeleDiet study)
por: Kaihara, Toshiki, et al.
Publicado: (2023)

Practice setting and secondary prevention of coronary artery disease
por: Jankowski, Piotr, et al.
Publicado: (2017)

Room for standardisation: the secondary prevention of coronary artery disease
por: Bahl, Rahul
Publicado: (2021)

Predictors and Outcomes of Secondary Prevention Medication in Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Li, Tianyu, et al.
Publicado: (2021)

Temporal changes in the secondary prevention of coronary artery disease in patients following myocardial revascularization
por: Kozieł, Paweł, et al.
Publicado: (2020)

Disparities in Secondary Prevention of Atherosclerotic Heart Disease After Coronary Artery Bypass Grafting in Northern Plains American Indians
por: Kruger, Hannah, et al.
Publicado: (2019)

Dual antiplatelet therapy for secondary prevention of coronary artery disease
por: Degrauwe, Sophie, et al.
Publicado: (2017)

Pharmacoeconomic Analysis of Clopidogrel in Secondary Prevention of Coronary Artery Disease
por: Cheng, Judy W.
Publicado: (2007)

Comparison of Secondary Prevention Status between Percutaneous Coronary Intervention and Coronary Artery Bypass Patients
por: Gao, Xia-qing, et al.
Publicado: (2017)

Smartphones in the secondary prevention of cardiovascular disease: a systematic review
por: Hamilton, Sandra J., et al.
Publicado: (2018)

The Effects of Glucose Lowering Agents on the Secondary Prevention of Coronary Artery Disease in Patients with Type 2 Diabetes
por: Jung, Inha, et al.
Publicado: (2021)

Secondary prevention in coronary artery disease: development and content validity of educational messages for mobile phones
por: Vieira, Lucas Verzegnassi, et al.
Publicado: (2023)

Adherence to coronary artery disease secondary prevention medicines: exploring modifiable barriers
por: Khatib, Rani, et al.
Publicado: (2019)

Personalized allocation of acetylsalicylic acid therapy for secondary prevention of coronary artery disease
por: Hegde, Nischal N., et al.
Publicado: (2022)

Propensity-score-matched comparison of safety, efficacy, and outcome of intravascular lithotripsy versus high-pressure PTCA in coronary calcified lesions
por: Aksoy, Adem, et al.
Publicado: (2021)

Adherence to secondary prevention recommendations after coronary artery bypass graft surgery
por: Keating, Taya, et al.
Publicado: (2022)

CHA(2)DS(2)-VASC score predicts coronary artery disease progression and mortality after ventricular arrhythmia in patients with implantable cardioverter-defibrillator
por: Kavsur, Refik, et al.
Publicado: (2021)

Physical Activity in the Prevention and Treatment of Coronary Artery Disease
por: Winzer, Ephraim Bernhard, et al.
Publicado: (2018)

The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands
por: Jørstad, H. T., et al.
Publicado: (2020)

Health literacy interventions for secondary prevention of coronary artery disease: a scoping review
por: Beauchamp, Alison, et al.
Publicado: (2022)

Physical activity and sedentary behaviour in secondary prevention of coronary artery disease: A review
por: Vasankari, Ville, et al.
Publicado: (2021)

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
por: Paolisso, Pasquale, et al.
Publicado: (2020)

Guideline-directed medical therapy for secondary prevention after coronary artery bypass grafting in patients with depression()
por: Stenman, Malin, et al.
Publicado: (2014)

Revisiting secondary prevention in coronary heart disease
por: Sigamani, Alben, et al.
Publicado: (2022)

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study
por: Zengin, Elvin, et al.
Publicado: (2015)

Modes of e-Health delivery in secondary prevention programmes for patients with coronary artery disease: a systematic review
por: Brørs, Gunhild, et al.
Publicado: (2019)

Triglyceride-glucose index is associated with symptomatic coronary artery disease in patients in secondary care
por: da Silva, Alessandra, et al.
Publicado: (2019)

Secondary prevention therapies in acute coronary syndrome and relation to outcomes: observational study
por: Chow, Clara K, et al.
Publicado: (2019)

Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Coronary Heart Disease (PROSPECTIVE)
por: Yamashita, Shizuya, et al.
Publicado: (2021)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
por: Chang, Hyoung Woo, et al.
Publicado: (2019)

SMARTphone and social media-based Cardiac Rehabilitation and Secondary Prevention (SMART-CR/SP) for patients with coronary heart disease in China: a randomised controlled trial protocol
por: Dorje, Tashi, et al.
Publicado: (2018)

Reversible Cause of Cardiac Arrest and Secondary Prevention Implantable Cardioverter Defibrillators in Patients With Coronary Artery Disease: Value of Complete Revascularization and LGE‐CMR
por: van der Lingen, Anne‐Lotte C. J., et al.
Publicado: (2021)

Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial
por: Kaldal, Anete, et al.
Publicado: (2021)

Association of Troponin T measurements with long-term outcomes in patients with coronary artery disease participating in a secondary prevention trial
por: Kaldal, Anete, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5npcv43t59v0vanqjavnq05v5i